The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Urinary-based detection of MSL, HE4, and CA125 as an additional dimension for predictive and prognostic modelling in ovarian cancer.
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Clovis Oncology GmbH; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology GmbH; Eisai Germany; Eisai Germany; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche Pharma AG; Tesaro; Teva
Travel, Accommodations, Expenses - Roche Pharma AG
 
Franziska Maria Schwarz
No Relationships to Disclose
 
Daniel Klotz
No Relationships to Disclose
 
Jan Dominik Kuhlmann
No Relationships to Disclose